Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links. | Science | 2017 | 28912134 | PubTator, text mining | PubMed |
| Functional Insights into ANP32A-Dependent Influenza A Virus Polymerase Host Restriction. | Cell Rep | 2017 | 28903035 | PubTator, text mining | PubMed |
| Genomic profile of oral squamous cell carcinomas with an adjacent leukoplakia or with an erythroleukoplakia that evolved after the treatment of primary tumor: A report of two cases. | Mol Med Rep | 2017 | 28901451 | PubTator, text mining | PubMed |
| Characterisation of the biflavonoid hinokiflavone as a pre-mRNA splicing modulator that inhibits SENP. | Elife | 2017 | 28884683 | PubTator, text mining | PubMed |
| C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation. | J Cell Sci | 2017 | 28851805 | PubTator, text mining | PubMed |
| Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies. | Front Mol Biosci | 2017 | 28848737 | PubTator, text mining | PubMed |
| Lighting Up T Lymphocyte Signaling with Quantitative Phosphoproteomics. | Front Immunol | 2017 | 28848546 | PubTator, text mining | PubMed |
| SUMO, a small, but powerful, regulator of double-strand break repair. | Philos Trans R Soc Lond B Biol Sci | 2017 | 28847818 | PubTator, text mining | PubMed |
| HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells. | Nat Commun | 2017 | 28842558 | PubTator, text mining | PubMed |
| Anti-inflammatory Mechanisms Triggered by Apoptotic Cells during Their Clearance. | Front Immunol | 2017 | 28824635 | PubTator, text mining | PubMed |
| Assessing predictions of fitness effects of missense mutations in SUMO-conjugating enzyme UBE2I. | Hum Mutat | 2017 | 28817247 | PubTator, text mining | PubMed |
| Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis. | Exp Ther Med | 2017 | 28810596 | PubTator, text mining | PubMed |
| Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes. | J Diabetes Investig | 2017 | 28796422 | PubTator, text mining | PubMed |
| Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming. | Sci Rep | 2017 | 28785061 | PubTator, text mining | PubMed |
| Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. | J Biol Chem | 2017 | 28784659 | PubTator, text mining | PubMed |
| Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors. | Viruses | 2017 | 28783105 | PubTator, text mining | PubMed |
| Machine Learning-Assisted Network Inference Approach to Identify a New Class of Genes that Coordinate the Functionality of Cancer Networks. | Sci Rep | 2017 | 28765560 | PubTator, text mining | PubMed |
| Increased SUMO-2/3-ylation mediated by SENP3 degradation is protective against cadmium-induced caspase 3-dependent cytotoxicity. | J Toxicol Sci | 2017 | 28747609 | PubTator, text mining | PubMed |
| DNA end resection requires constitutive sumoylation of CtIP by CBX4. | Nat Commun | 2017 | 28740167 | PubTator, text mining | PubMed |
| Distinct selective forces and Neanderthal introgression shaped genetic diversity at genes involved in neurodevelopmental disorders. | Sci Rep | 2017 | 28733602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=61